Trevena Inc - ESG Rating & Company Profile powered by AI
Other corporations in the rating peer group for Trevena Inc are displayedin the table. The article includes a questions and answers table on Trevena Inc. This report of Trevena Inc incorporates information from across the web as well as from public documents by Trevena Inc.
Trevena Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.5; made up of an environmental score of 2.7, social score of 4.8 and governance score of 6.0.
4.5
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 852 | Vaccibody AS | 4.6 | High |
| 852 | argenx SE | 4.6 | High |
| 868 | Trevena Inc | 4.5 | High |
| 868 | CARsgen Therapeutics Holdings Ltd | 4.5 | High |
| 868 | Boiron SA | 4.5 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Trevena Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Trevena Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Trevena Inc report the average age of the workforce?
Sign up for free to unlockDoes Trevena Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Trevena Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Trevena Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Trevena Inc offer flexible work?
Sign up for free to unlockDoes Trevena Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Trevena Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Trevena Inc conduct supply chain audits?
Sign up for free to unlockDoes Trevena Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Trevena Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Trevena Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Trevena Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Trevena Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Trevena Inc disclose water use targets?
Sign up for free to unlockDoes Trevena Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Trevena Inc have a product recall in the last two years?
Sign up for free to unlockDoes Trevena Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Trevena Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Trevena Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Trevena Inc disclose parental leave metrics?
Sign up for free to unlockDoes Trevena Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Trevena Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Trevena Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Trevena Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Trevena Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Trevena Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Trevena Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Trevena Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Trevena Inc disclose its waste policy?
Sign up for free to unlockDoes Trevena Inc report according to TCFD requirements?
Sign up for free to unlockDoes Trevena Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Trevena Inc disclose energy use targets?
Sign up for free to unlockDoes Trevena Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Trevena Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Trevena Inc
These potential risks are based on the size, segment and geographies of the company.
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV027 for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abnormal blood clotting in patients with COVID-19; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. The company has a collaboration with Imperial College London to evaluate Trv027 in Covid-19 patients. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.